Home

kerület Forró Diszkriminatív tumor marker renal cell carcinoma Hates Harmonikus Díj

PDF] Selected tumor markers in the routine diagnosis of chromophobe renal  cell carcinoma | Semantic Scholar
PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar

Renal Medullary Carcinoma: Establishing Standards in Practice | JCO  Oncology Practice
Renal Medullary Carcinoma: Establishing Standards in Practice | JCO Oncology Practice

Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell  Carcinoma Stem Cell-Like Cancer Cells | PLOS ONE
Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells | PLOS ONE

Potential molecular prognostic markers for renal cell carcinoma. | Download  Table
Potential molecular prognostic markers for renal cell carcinoma. | Download Table

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and  Angiogenesis Blockade - ScienceDirect
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade - ScienceDirect

Frontiers | Review of Prognostic Expression Markers for Clear Cell Renal  Cell Carcinoma
Frontiers | Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma

Cancers | Free Full-Text | Comprehensive Immunoprofiles of Renal Cell  Carcinoma Subtypes
Cancers | Free Full-Text | Comprehensive Immunoprofiles of Renal Cell Carcinoma Subtypes

PDF] Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal  cell carcinoma. | Semantic Scholar
PDF] Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. | Semantic Scholar

Diagnostics | Free Full-Text | Circulating Tumor Cells for the Management  of Renal Cell Carcinoma
Diagnostics | Free Full-Text | Circulating Tumor Cells for the Management of Renal Cell Carcinoma

Tumor and immune reprogramming during immunotherapy in advanced renal cell  carcinoma - ScienceDirect
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect

PDF] Selected tumor markers in the routine diagnosis of chromophobe renal  cell carcinoma | Semantic Scholar
PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar

The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and  survival in clear-cell renal cell carcinoma | PLOS ONE
The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma | PLOS ONE

Frontiers | Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy  in Metastatic Clear Cell Renal Cancer
Frontiers | Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer

Renal cell carcinoma - Knowledge @ AMBOSS
Renal cell carcinoma - Knowledge @ AMBOSS

Renal cell carcinoma: the search for a reliable biomarker - Farber -  Translational Cancer Research
Renal cell carcinoma: the search for a reliable biomarker - Farber - Translational Cancer Research

PDF] Selected tumor markers in the routine diagnosis of chromophobe renal  cell carcinoma | Semantic Scholar
PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar

Prediction of drug candidates for clear cell renal cell carcinoma using a  systems biology-based drug repositioning approach - eBioMedicine
Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach - eBioMedicine

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal  Cell Carcinoma - ScienceDirect
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma - ScienceDirect

c-Met is a prognostic marker and potential therapeutic target in clear cell  renal cell carcinoma. | Semantic Scholar
c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma. | Semantic Scholar

GRP78 expression in tumor and perinephric adipose tissue is not an optimal  risk stratification marker for clear cell renal cell carcinoma | PLOS ONE
GRP78 expression in tumor and perinephric adipose tissue is not an optimal risk stratification marker for clear cell renal cell carcinoma | PLOS ONE

PDF] Selected tumor markers in the routine diagnosis of chromophobe renal  cell carcinoma | Semantic Scholar
PDF] Selected tumor markers in the routine diagnosis of chromophobe renal cell carcinoma | Semantic Scholar

Suspected Malignancy B 陳建佑. Symptoms Red Urinary Hesitance Urination. - ppt  download
Suspected Malignancy B 陳建佑. Symptoms Red Urinary Hesitance Urination. - ppt download

A single-cell map of dynamic chromatin landscapes of immune cells in renal  cell carcinoma | Nature Cancer
A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma | Nature Cancer

Renal Cell Carcinoma - Cancer Therapy Advisor
Renal Cell Carcinoma - Cancer Therapy Advisor

Marker-based RCC CSC phenotypes | Download Table
Marker-based RCC CSC phenotypes | Download Table